Clinical trials · Boston, MA
Hidradenitis Suppurativa clinical trials in Boston
We’re tracking 12 recruiting hidradenitis suppurativa studies with a site in or near Boston — including Phase 1, Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Boston
- NCT07228390RecruitingPhase 2
Testing ritlecitinib for hidradenitis suppurativa in adults
This study tests an oral medicine called ritlecitinib for moderate to severe hidradenitis suppurativa (HS) in adults who haven't responded well to antibiotics. The goal is to see if it can reduce painful red lumps and improve quality of life.
Boston, MassachusettsAges 18–75 - NCT05889182RecruitingPhase 3
Testing an oral medicine for moderate to severe hidradenitis
This Phase 3 study tests upadacitinib taken by mouth to reduce hidradenitis suppurativa (HS) symptoms and disease activity, and to track side effects. It is for people who have already tried anti-TNF treatments and still had inadequate response or couldn’t tolerate them.
Boston, MassachusettsAges 12 years+ - NCT07384975RecruitingPhase 2
New drug NAV-240 for hidradenitis suppurativa
This trial tests a new drug called NAV-240 for people with hidradenitis suppurativa (HS) who have not had success with antibiotics. The goal is to see if the drug can reduce the number of painful lumps and improve symptoms.
Boston, MassachusettsAges 18–70 - NCT07244263RecruitingPhase 2
Zasocitinib for hidradenitis suppurativa
This trial tests a new daily pill called zasocitinib for people with moderate to severe hidradenitis suppurativa (HS) who haven't been helped enough by antibiotics. It aims to reduce painful lumps and abscesses.
Boston, MassachusettsAges 18 years+ - NCT07123038Recruiting
Long-term safety study for gene-modified Treg therapy recipients
This study follows people who previously received a gene-modified Treg (regulatory T cell) therapy from Sonoma Biotherapeutics. It checks for long-term safety and does not involve any new treatment.
Boston, MassachusettsAges 18–71 - NCT07263230RecruitingPhase 2
Roflumilast Foam for Hidradenitis Suppurativa
This study tests whether roflumilast foam (a prescription foam) is safe and can reduce inflamed bumps in people with mild-to-moderate hidradenitis suppurativa (HS) who do not have draining tunnels. Participants will stop other HS treatments during the trial.
Boston, MassachusettsAges 18 years+ - NCT06888193RecruitingPhase 1
Bimekizumab in breast milk of mothers being treated
This study measures how much bimekizumab (Bimzelx) gets into breast milk. It helps us understand if the medicine is safe for breastfeeding babies whose mothers take this drug.
Boston, MassachusettsAges 18 years+ - NCT07007637Enrolling by invitationPhase 3
Long-Term Safety and Effectiveness of Sonelokimab for Hidradenitis Suppurativa
This study offers long-term treatment with an investigational biologic, sonelokimab, for people with moderate to severe hidradenitis suppurativa who finished an earlier sonelokimab study. The goal is to see if sonelokimab remains safe and effective over time.
Boston, MassachusettsAges 12 years+ - NCT07213973RecruitingPhase 2
Study of povorcitinib for teens with hidradenitis suppurativa
This trial tests an oral medication called povorcitinib for adolescents aged 12–17 with moderate to severe hidradenitis suppurativa (HS) that hasn't improved with standard treatments like antibiotics. It aims to see how well the drug works and if it's safe.
Boston, MassachusettsAges 12–17 - NCT06855498RecruitingPhase 3
Rollover study for patients who took povorcitinib before
This study is for people who have already taken the study drug povorcitinib in a previous trial and found it helpful. It lets you continue receiving the treatment and allows doctors to keep tracking its long-term safety and effects.
Boston, MassachusettsAges 18 years+ - NCT05403710Recruiting
Botox injections for people with hidradenitis suppurativa
This trial studies whether botulinum toxin (Botox) injections can improve hidradenitis suppurativa (HS), a painful skin condition with recurring bumps and tunnels. You might be a good match if you have long-lasting HS in more than one body area and can safely do skin-area treatment visits (including skin biopsy if needed).
Worcester, MassachusettsAges 18–75 - NCT07170917RecruitingPhase 2
Testing a new drug for moderate to severe hidradenitis suppurativa
This trial tests a new drug called Brivekimig for people with moderate to severe hidradenitis suppurativa (HS) who have not gotten enough relief from oral antibiotics. The goal is to see if it can reduce abscesses and inflamed bumps.
Johnston, Rhode IslandAges 18 years+
Hear when a new Hidradenitis Suppurativa trial opens near Boston, MA
We’ll email you when one opens near Boston, MA — at most once a week, no account needed, unsubscribe anytime.
Hidradenitis Suppurativa trials in other cities
Where these studies are running near Boston
Institutions with a site for the recruiting hidradenitis suppurativa studies listed above.
- Beth Israel Deaconess Medical Center · 5 studies
- Massachusetts General Hospital · 2 studies
- Beacon Clinical Research, LLC
- Boston Children's Hospital
- Brigham and Women's Hospital
- Clinical Partners- Site Number : 8400002
- Clinical Site
- Investigative Site US030
What taking part in a hidradenitis suppurativa study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting hidradenitis suppurativa studies in Massachusetts.
Common questions
- Are there hidradenitis suppurativa clinical trials near Boston?
- Yes. We're currently tracking 12 recruiting hidradenitis suppurativa studies with a site near Boston, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a hidradenitis suppurativa study near Boston?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Boston to take part?
- Not necessarily. These studies have a site near Boston, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a hidradenitis suppurativa trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New hidradenitis suppurativa studies open near Boston regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.